GlobeNewswire Inc | Sep 9, 2020 07:31AM EDT

September 09, 2020

ROCHESTER, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, providers and patients, has been invited to participate in two investor conferences being held in September.

Event: H.C. Wainwrights 22nd Annual Global Investment ConferenceDate: September 14-16, 2020Format: 1x1 meetings and live company presentationWebcast date and time: September 16th at 1:00 p.m. EDTWebcast link: click herePlease contact your H.C. Wainwright institutional sales representative for registration information.

Event: Lake Street Capital Markets 4th Annual Best Ideas Growth (BIG4) ConferenceDate: September 17, 2020Format: 1x1 meetingsPlease contact your Lake Street institutional sales representative for registration information.

OptimizeRx management is scheduled to participate in virtual one-on-one meetings with institutional investors and analysts at both conferences.

Management will discuss how OptimizeRxs growing digital point-of-care solutions have evolved into must-haves for life science companies looking to improve essential communications with physicians and patients.

They will also discuss the companys recent expansion of its digital health platform from ambulatory and acute care to retail pharmacy, which includes access to a new nationwide network of 10,000 FDA-cleared self-screening Smart Health Stations.

To schedule a virtual one-on-one meeting with OptimizeRx, you may submit your request via the links provided upon your registration for the conferences. For any questions about OptimizeRx, please contact Ron Both of CMA at (949) 432-7557 or submit your request here.

About H.C. WainwrightH.C. Wainwright is a fullservice investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions.H.C. Wainwright & Co. also provides research and sales and trading services to institutional investors.According to Sagient Research Systems, H.C. Wainwrights team is ranked as the #1 Placement Agent in terms of aggregate CMPO (confidentially marketed public offering), RD (registered direct offering) and PIPE (private investment in public equity) executed cumulatively since 1998. For more information about H.C. Wainwright, visit www.hcwco.com.

About Lake Street Capital MarketsLake Street Capital Markets is a research-powered investment bank focused on select, high-growth companies and sectors of the economy. Their research enables institutional investors to understand emerging secular trends and identify innovative companies best positioned to capitalize on them. Lake Street provides companies with access to capital and helps build relationships to drive long-term growth. At the core of everything it does is their commitment to providing informed advice and exceptional service to its clients. For more information about Lake Street, visit www.lakestreetcapitalmarkets.com.

About OptimizeRxOptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRxs network reaches more than 60% of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a providers workflow through leading electronic health platforms. OptimizeRxs fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes.

For more information, follow the company onTwitter,LinkedInor visitwww.optimizerx.com.

Important Cautions Regarding Forward Looking StatementsThis press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

OptimizeRxContactDoug Baker, CFOTel (248) 651-6568 (x807)dbaker@optimizerx.com

Media Relations ContactMaira Alejandra, Media Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com

Investor Relations ContactRon Both, CMATel (949) 432-7557oprx@cma.team